跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,441 条关于
“biliary tract”
全部
7,441
临床试验
5,594
药物
145
机构
22
资讯
1,680
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
去年
SWOG S1815: Nab-Paclitaxel Addition to Standard Chemotherapy Under Investigation for Advanced Biliary Tract Cancer
去年
Triplet Chemotherapy Fails to Improve Survival in Advanced Biliary Tract Cancer
去年
Targeted Therapies Transform Biliary Tract Cancer Treatment Landscape with FGFR2 Inhibitors Leading Clinical Advances
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
去年
Eisai Seeks Japanese Approval for Novel FGFR Inhibitor Tasurgratinib in Biliary Tract Cancer
去年
Cyclacel's Plogosertib Shows Promise Against Biliary Tract Cancer in Preclinical Study
去年
China Approves Zanidatamab as First Dual HER2-Targeted Bispecific Antibody for Biliary Tract Cancer
去年
FDA Approves Zanidatamab (Ziihera®) for HER2-Positive Biliary Tract Cancers
去年
FDA Grants Accelerated Approval to Zanidatamab for HER2-Positive Biliary Tract Cancer
第 1 页,共 168 页
上一页
下一页